Edition:
United States

Search Results  for 'IPO-AST.N'

Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Asterias Biotherapeutics Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

20 Aug 2016 Reuters Investment Profile 12 $20.00

ASTERIAS BIOTHERAPEUTICS INC (AST=US) - SHORT AND LONG TERM FORECASTS FOR ACTIVE TRADERS

"www.pechala.com, the world's largest market forecasting firm with subscribers in 83 different countries provide forecasts of...

27 Aug 2016 Pechala's Reports 2 $25.00

Thomson Reuters Stock Report - Asterias Biotherapeutics Inc (AST-A)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

26 Aug 2016 Thomson Reuters Stock Report 12 $25.00

Value Graph: ASTERIAS BIOTHER -- AST

26 Aug 2016 Ford Investor Services, Inc. 1 $12.00

ValuEngine Rating and Forecast Report for AST

Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and...

14 Aug 2016 ValuEngine, Inc. 11 $25.00

Interview with the CEO: Asterias Biotherapeutics, Inc. (NYSEMKT:AST)

12 Aug 2016 Wall Street Transcript ,The 5 $50.00

Wright Investors Service Comprehensive Report for Asterias Biotherapeutics Inc

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

24 Jul 2016 Wright Reports 57 $75.00

Company Snapshot - Asterias Biotherapeutics Inc

A director at Asterias Biotherapeutics Inc bought 50,000 shares at 2.931USD and the significance rating of the trade was 50/1...

13 Jun 2016 Directors Deals Ltd. 1 $12.00

Thomson Reuters Stock Report - Asterias Biotherapeutics Inc (AST-A)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

10 May 2016 Thomson Reuters Stock Report 12 $25.00

AST.A - Event Transcript of Asterias Biotherapeutics Inc conference call, Mar. 29, 2016 / 4:30PM ET

Edited Event Transcript of AST.A conference call, Mar. 29, 2016 / 4:30PM ET Boston, Mar 31, 2016 (Thomson StreetEvents)...

29 Mar 2016 Thomson Reuters StreetEvents 11 $75.00